Indeed, in the CT26 mouse colon cancer model, which is based on the subcutaneous injection of colon tumor cells, CCR5-deficient mice could be characterized by significantly decreased numbers of tumor-infiltrating Treg cells and reduced tumor growth [51]. Here, CCR5 is linked to malignant colon neoplasm.